TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Amber BioSciences AB
Closing information (x1000 EUR)
| Closing information | 2024/04 | 2023/04 | 2022/04 |
| Turnover |
11
|
12
|
12 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
3
|
5
|
4 |
| EBITDA |
3
|
5
|
4 |
| Total assets |
108
|
109
|
120 |
| Current assets |
29
|
26
|
30 |
| Current liabilities |
0
|
2
|
7 |
| Equity capital |
31
|
30
|
0 |
| - share capital |
9
|
9
|
0 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/04 | 2023/04 | 2022/04 |
| Solvency |
28.7%
|
27.5%
|
0% |
| Turnover per employee |
11
|
12
|
12 |
| Profit as a percentage of turnover |
27.3%
|
41.7%
|
33.3% |
| Return on assets (ROA) |
2.8%
|
4.6%
|
3.3% |
| Current ratio |
1300%
|
428.6% | |
| Return on equity (ROE) |
9.7%
|
16.7% | |
| Change turnover |
-1
|
1
|
1 |
| Change turnover % |
-7%
|
13%
|
14% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/04 | 2023/04 | 2022/04 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.